Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Journal of Clinical Psychopharmacology
|
June 25, 2025
How Does Drug Company Marketing Affect Physician Prescribing?
Jeffrey A Mattes
Archives of General Psychiatry
|
November 3, 2010
Bipolar disorder?
Jeffrey A Mattes
The Journal of Clinical Psychiatry
|
February 1, 2008
Levetiracetam in patients with impulsive aggression: a double-blind, placebo-controlled trial
Jeffrey A Mattes
The American Journal of Psychiatry
|
November 1, 2006
Antabuse reaction with ceftin
Jeffrey A Mattes
Journal of Clinical Psychopharmacology
|
November 12, 2005
Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial
Jeffrey A Mattes
The American Journal of Psychiatry
|
August 31, 2007
Understanding schizophrenia
Jeffrey A Mattes
The American Journal of Psychiatry
|
September 3, 2014
Right versus left hippocampal activity as a biomarker in schizophrenia
Jeffrey A Mattes
The Journal of Neuropsychiatry and Clinical Neurosciences
|
February 18, 2010
Suggested improvements to the overt aggression scale-modified
Jeffrey A Mattes
The American Journal of Psychiatry
|
September 2, 2006
Less mood switching with venlafaxine?
Jeffrey A Mattes
The American Journal of Psychiatry
|
December 2, 2021
Ketamine After Two Antidepressants?
Jeffrey A Mattes
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Journal of Clinical Psychopharmacology
|
June 25, 2025
How Does Drug Company Marketing Affect Physician Prescribing?
Jeffrey A Mattes
Archives of General Psychiatry
|
November 3, 2010
Bipolar disorder?
Jeffrey A Mattes
The Journal of Clinical Psychiatry
|
February 1, 2008
Levetiracetam in patients with impulsive aggression: a double-blind, placebo-controlled trial
Jeffrey A Mattes
The American Journal of Psychiatry
|
November 1, 2006
Antabuse reaction with ceftin
Jeffrey A Mattes
Journal of Clinical Psychopharmacology
|
November 12, 2005
Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial
Jeffrey A Mattes
The American Journal of Psychiatry
|
August 31, 2007
Understanding schizophrenia
Jeffrey A Mattes
The American Journal of Psychiatry
|
September 3, 2014
Right versus left hippocampal activity as a biomarker in schizophrenia
Jeffrey A Mattes
The Journal of Neuropsychiatry and Clinical Neurosciences
|
February 18, 2010
Suggested improvements to the overt aggression scale-modified
Jeffrey A Mattes
The American Journal of Psychiatry
|
September 2, 2006
Less mood switching with venlafaxine?
Jeffrey A Mattes
The American Journal of Psychiatry
|
December 2, 2021
Ketamine After Two Antidepressants?
Jeffrey A Mattes
Page
of 3